Skip to main content
Download PDF

The effective function of circular RNA in colorectal cancer

Cancer Cell International volume 21, Article number: 496 (2021) Cite this article

Abstract

Colorectal cancer (CRC) is the 3rd most common type of cancer worldwide. Late detection plays role in one-third of annual mortality due to CRC. Therefore, it is essential to find a precise and optimal diagnostic and prognostic biomarker for the identification and treatment of colorectal tumorigenesis. Covalently closed, circular RNAs (circRNAs) are a class of non-coding RNAs, which can have the same function as microRNA (miRNA) sponges, as regulators of splicing and transcription, and as interactors with RNA-binding proteins (RBPs). Therefore, circRNAs have been investigated as specific targets for diagnostic and prognostic detection of CRC. These non-coding RNAs are also linked to metastasis, proliferation, differentiation, migration, angiogenesis, apoptosis, and drug resistance, illustrating the importance of understanding their involvement in the molecular mechanisms of development and progression of CRC. In this review, we present a detailed summary of recent findings relating to the dysregulation of circRNAs and their potential role in CRC.

Background

Colorectal cancer (CRC) is one of the most common malignancies ranking third in the incidence and second in mortality among other cancers in the world. The global incidence of CRC is increasing, with approximately 3640 deaths and 17,930 new cases in 2020 [1, 2]. The exact mechanisms underlying CRC development remain unknown, however, risk factors that are strongly related to CRC include genetics, diet, tobacco smoking, heavy alcohol consumption, inactive lifestyle and age, where > 50 is a significant risk factor for CRC. However, recent evidence has also detected an increased risk for young adults [3]. Clearly the disorder is multifactorial in nature, with no common identifiable predictor of pre-disposition [4]. Here, we will review the molecular evidence to date.

Genetic and epigenetic alterations have both been found in CRC patients; changes in chromosomal copy number, aberrant gene methylation, and dysregulated gene expression, including tumor suppressor genes such as APC, BRAF, DCC, TP53, SMAD4, SMAD2, oncogenes such as KRAS and NRAS, and DNA repair genes including MLH1 and MSH6 [5, 6].

Dividing these mutation types into functional pathways broadly identifies three separate mechanisms: Chromosomal instability, which is the most common cause of genomic instability in CRC, significantly linked to alterations in APC and KRAS genes [7, 8]. In hereditary and sporadic colorectal cancer, microsatellite instability (MSI) is another key pathway. Germline mutation in one of the DNA mismatch repair genes, MLH1, MSH2, MSH6, or PMS2 leads to hereditary nonpolyposis colorectal cancer (HNPCC), while MSI in sporadic colorectal cancer is predominantly due to hypermethylation of the MLH1 promoter and sometimes sporadic mutations [9]. Defects in the mismatch repair mechanisms can also lead to MSI status [10]. A third pathway is via epigenetic alteration. CpG island methylator phenotype (CIMP) differences can result in changes in gene expression or function without changing the DNA sequence of that particular gene [11]. Taken together; these three pathways indicate the genetic heterogeneity of CRC.

CRCs are classified into 4 subtypes: CMS1-CMS4 with different clinical and biological characterizations [12]. Despite recent advances in our knowledge of signaling pathways involved in CRC, chemo- and radiotherapy resistance remains the most significant hurdle in CRC treatment. Therefore, a novel methodology for improved early diagnosis is essential. Non-coding RNAs (ncRNAs) play important roles in the regulation of chemo-and radio resistance of CRC [13]. Thus, ncRNAs could serve as targets for the development of new therapeutic strategies for drug and radiation resistance in CRC [14, 15]. circRNAs are a significant facet in ncRNAs biology, thus understanding of the role of circRNAs in CRC progression is pivotal to identifying new diagnostic, prognostic and predictive biomarkers for CRC [16]. In this review, we summarize the potential clinical implications of human circRNAs in CRC, for use as predictive biomarkers and/or therapeutic targets.

The non-coding RNAs

The majority of the human genome (~ 90%) is transcribed as ncRNAs, which contain multiple classes of RNAs with various lengths [17]. Many studies have identified functional roles for ncRNAs, in various physiological and pathological processes, such as diabetes, cardiovascular disease, and cancer [18,19,20]. Classes of short ncRNAs include microRNAs (miRNAs), small interfering RNAs (siRNAs) and short piwi-interacting RNAs (piRNAs), meanwhile, linear lncRNAs (long non-coding RNAs) and circular RNAs are both classed as long noncoding RNAs [21]. circRNAs, however, are a new class of long ncRNAs, processing largely from exotic or intronic sequences, and are remarkably unique in structure and chemical characteristics compared with linear RNAs. circRNA biogenesis is based on the back‐splicing process, and closed 5-3ʹ ends negate degradation by RNA exonuclease or RNase R [22]. Classification of circRNAs is largely based on sequence origin, where subgroups include the circular intronic RNAs (ciRNAs), the exonic circRNAs (EcircRNAs), and exon–intron circRNAs (EIciRNAs) [23]. EcircRNAs, which predominantly exist in the cytoplasm, comprise the majority of all circRNAs. EcircRNAs can be formed by three different mechanisms, including lariat-driven circularization, RNA-binding protein (RBP)-driven circularization, and back splicing. EIciRNAs however, are formed only by back splicing of ciRNAs, which depends on a 7-nt GU-rich element and an 11-nt C-rich element, important in escaping debranching and exonucleolytic degradation [23, 24]. circRNAs have relatively stable structure and show tissue-specific expression, also displaying developmental stage regulation, with evolutionary conservation among species [25].

Functions of circRNAs

circRNAs have regulatory roles in gene expression by sponging miRNAs, competing with other RNAs for binding to miRNAs and RNA binding proteins (RBPs) to modulate the local concentration of RBPs and RNAs as part of the competing endogenous RNA (ceRNA) network [26]. circRNAcircRNACDR1as (ciRS-7), for example, which has more than 70 conserved binding sites for miR-7, and is highly expressed in human and mouse brains [27, 28]. SRY, which encodes both linear and circular RNAs, is involved in sex determination in testis development. circRNA SRY can control metastasis and invasion of tumor cells via sponging miR-138 [29, 30]. Another circRNA, known as CircITCH, plays similar roles as a miRNA sponge, via miR-7, miR-17, and miR214, to inhibit proliferation through the Wnt/β-catenin signaling pathway [31], which is illustrated in Fig. 1A.

Fig. 1
figure 1

(A) Circ0001313 was found to be the most significantly upregulated circular RNA in CRC. where it can sponge miR-338 and affect apoptosis radiosensitivity in CRC. (B) Circ-ITCH is overexpressed in colorectal cancer and it can develop proliferation by sponging miR7, miR214, miR17 via Wnt/ β-catenin pathway signaling

Full size image

Although circRNAs are considered to be non-coding RNAs due to lack of 5’-cap structure and 3’-polyadenylation tail, circRNAs have been shown to generate protein products in a cap-independent manner [32]. Interestingly, many circRNAs are sometimes translated, indeed using high-content genomic screening, Legnini et al. found Circ-ZNF609 can translate into a protein in a splicing-dependent and cap-independent manner [33]. Yang Y et al. discovered CircFBXW7, produced from the FBXW7 gene, encoding a novel 21-kDa protein FBXW7-185aa, which reduced the half-life of c-Myc by antagonizing USP28-induced c-Myc stabilization [34].

The overall activities of circRNAs are intricately intertwined with RNA binding proteins, modulating the stability of mRNAs, regulating gene transcription, and translating proteins [35] and are involved in the regulation of cell proliferation, pluripotency and early lineage differentiation, epithelial-mesenchymal transition (EMT), cancer progression and chemoradiotherapy resistance, as shown in Fig. 2.

Fig. 2
figure 2

circRNAs and their targeted pathways in CRC including carcinogenesis, metastasis, and chemoresistance

Full size image

Upregulation of circRNAs in CRC

Among all the validated aberrantly expressed circRNAs in colorectal cancer, upregulation of circRNAs more often associates with oncogenesis. Xia et al. found abnormally expressed circRNAs through CircRNA high-throughput sequencing, identifying Circ-0053277 as having the ability to sponge miR‐2467‐3p, and as being significantly upregulated in CRC tissues, where it facilitated CRC cell migration, proliferation, and epithelial‐mesenchymal transition [36]. Similarly, Li et al. identified CircVAPA as being upregulated in tissues and plasma, serving as a sponge for miR-101. Furthermore, they showed that the expression level of miR-125a was decreased in CRC cells, and CircVAPA knockdown repressed CRC cells cycle progression, invasion, and migration [37]. Knockdown of CircVAPA can also suppress CRC cell cycle progression, invasion, and migration by sponging miR-125a [38].

Yahang et al. found that Hsa_Circ_0026416 which was upregulated in CRC tissues and plasma, and has a key role in promoting the progression of CRC both in vitro and in vivo, may function as a ceRNA to sponge miR-346 [39].

Knockdown of another upregulated circRNA, CircACAP2 (hsa_circ_0007331), which was reported to be significantly upregulated in CRC tissues and colon cancer cells lines, suppressed proliferation and invasion by downregulating T lymphoma invasion and metastasis protein 1 (Tiam1) expression, through upregulated miR-21-5p expression (40). Another highly overexpressed circRNA in CRC is Hsa_circ_0136666, derived from the PRKDC gene, which can regulate proliferation and migration of CRC cells by sponging miR-136 [41].

Downregulated circRNAs in CRC

As well as being overexpressed, other circRNAs are downregulated in CRC. Wang X et al. showed hsa_Circ_001988 was significantly downregulated in 31 matched colorectal cancer tissue samples, proposing this circRNA as a novel diagnosis potential biomarker in the CRC [42]. Geng Y reported hsa_Circ_0009361 to be significantly downregulated in both CRC tissues and derived cells. circRNA promoting the proliferation, epithelial-mesenchymal transition, migration, and invasion of CRC cells by sponging of miR-582. Conversely, overexpression of hsa_Circ_0009361 caused upregulation in the expression of adenomatous polyposis coli 2 (APC2) and blocked the activity of the Wnt/β-catenin pathway [43]. Circ-ITGA7, which sponges’ miR-370-3p to increase ITGA7 transcription–, through inhibition of RREB1 via oncogenic Ras has been shown to be down-regulated in CRC tissue samples [44]. Indeed, Circ-ITGA7 has also been shown to directly act as a tumor suppressor in CRC, with clinical features including cancer differentiation, lymph node metastasis, distant metastasis, and alterations in the TNM stage [45]. circRNA Circ-FBXW7 silencing was previously reported to enhance the proliferation, cell migration, and invasion of CRC cells in culture. In contrast, overexpression of Circ-FBXW7 significantly suppressed CRC cell proliferation, migration, and invasion. Similarly, Circ-FBXW7 silencing was also shown to stimulate tumor growth in SW480 and SW620 tumor models, whereas Circ-FBXW7 overexpression repressed tumor progression in the same system. This suggests that Circ-FBXW7 could serve as a target biomarker of CRC. Potential mechanisms have been proposed, including upregulated mRNA and protein expressions of NEK2 and mTOR, and diminished the PTEN expression (46). circRNACirc_021977 is another circRNA found to be down-regulated in CRC. Circ_021977 was shown to sponge miR-10b-5p, with a regulatory axis inhibiting proliferation, migration, and invasion in CRC via p21 and p53 [47]. Dysregulated circRNA expression in CRC is summarized in Table 1.

Table 1 The characteristics of dysregulated circRNAs in CRC
Full size table

circRNAs in predicting response to chemoradiotherapy

Targeted therapy, chemotherapy, and multiagent regimens, for example, FOLFIRI (5-FU and irinotecan) and FOLFOX (5-FU oxaliplatin) can be applied as the standard treatment of CRC. However, chemotherapy has its limitations, including toxicity, low response rates, unpredictable innate and acquired resistance mechanisms, and low tumor-specific selectivity [137]. Recent studies have shown that different ncRNAs such as circRNAs, may play important roles in the regulation of chemoresistance and affect the sensitivity of tumors to chemotherapy and radiotherapy through modification of various signaling pathways, including cell cycle, proliferation, apoptosis, and DNA damage repair [84, 112]. hsa_circRNA_0001313 is one of the upregulated circRNAs in radio-resistant CRC tissues. Inhibition of hsa_circRNA_0001313 induces radio-sensitivity, reduced cell viability, and increases caspase-3 activity and colony formation by negatively modifying miR-338-3p in CRC cells, which has shown in Fig. 1B [124]. Another recent study reported that CircDDX17 was down-regulated in CRC, and its overexpression induced inhibition of 5-Fu resistance, blocked tumor growth, and CRC progression via sponging miR-31-5p [131]. Interestingly, Circ-32883 was upregulated in CRC tissues and its overexpression was positively associated with chemoresistance through its potential action as a sponge for miR-501-5p. This miRNA binds to EML5 mRNA, inhibiting its expression. Thus, promoting resistance to FOLFOX therapy [112]. Other circRNAs related to chemotherapy resistance are summarized in Table 2.

Table 2 The characteristics of circRNAs in CRC as a chemotherapy resistance
Full size table

circRNAs as biomarkers for colorectal cancer

Through improvements in high-throughput sequencing, circRNA microarray, and chip analysis we now know circRNAs are differentially expressed in CRC, and certain circRNAs are involved in various biological processes such as proliferation, migration, invasion, and apoptosis. Due to the unique structure of circRNAs, which confers resistance to RNase and longer half-lives, they can therefore be potential candidates for diagnostic biomarkers. However, the underlying biological function of circRNAs requires further investigation [138, 139].

Several circRNAs have been proposed as useful therapeutic targets for CRC. For instance, hsa_circ_022382 which is derived from the human FADS2 gene is overexpressed in 200 CRC tissues, where CircFADS2 overexpression was positively associated with clinicopathological features. CircFADS2 expression may therefore be a promising biomarker for prognostic investigation in CRC patients [95]. In another study, hsa_circ_0026344 was shown to be significantly down-regulated in 32 CRC patients compared to paired adjacent non-tumorous tissues. The expression of hsa_circ_0026344 was correlated with tumor size and lymph metastasis. Functionally, circRNA-0026344 overexpression significantly suppressed CRC cell proliferation and colony formation as well as promoted apoptosis by regulating miR-21 and miR-31 levels [45]. Other circRNAs with biomarker potential are summarized in Table 3.

Table 3 circRNAs with Biomarker potential in CRC
Full size table

circRNAs as therapeutic targets in colorectal cancer

Targeted therapy has been widely used in the clinic due to its excellent efficacy, and it can work on cancerous cells by directly inhibiting cell proliferation, differentiation, and migration [50]. Indeed, monoclonal antibodies, for instance, are currently an important player in targeted therapies [51]. circRNAs moderate drug resistance by sponging microRNAs both in traditional chemotherapeutic drugs, advanced targeted drugs, and immunotherapeutic drugs. For example, therapeutic targeting of ciRS-7 may become a promising strategy for colorectal cancer patients, since higher expression of ciRS-7 correlated with multiple clinicopathologic factors, such as advanced T-stage, lymph node, and distant metastasis, and ciRS-7 overexpression promotes the EGFR/RAF1/MAPK pathway by inhibiting miR-7 activity [121, 155]. Yang et al. indicated that high expression of circPTK2 positively correlated with poorer survival, showing CircPTK2 can bind to vimentin and promote EMT growth and metastasis in CRC cells, therefore ciRS-7 may become a therapeutic target for CRC metastasis [51]. The relation between circPTK2 in CRC is shown in Fig. 3.

Fig. 3
figure 3

CircPTK2 is overexpressed in CRC tissues and is associated with tumor metastasis

Full size image

Another highly expressed circRNA in CRC tissue is Circ_001680 which was observed to enhance the proliferation and migration capacity of CRC cells. Fluorescence reporter assays confirmed that circ_001680 alters the expression of BMI1 by targeting miR-340. More importantly, Circ_001680 was found to promote the propogation of cancer stem cells in CRC and induce resistance against Irinote by modifying the miR-340 target gene BMI1 n [53]. Safe and effective delivery of ncRNAs is a significant therapeutic paradigm for all cancers. Since unmodified oligonucleotides are not stable in circulation, modifications of oligonucleotides are essential to increasing efficacy and stability. Most current oligonucleotide therapies need an additional delivery system to achieve these desired biological effects. Several options need to be considered in selecting a delivery system, including stability, evasion of the innate immune system, avoidance of non-specific interactions with serum proteins, and non-target cells. One of the common strategies to increase the circulation time for therapeutic oligonucleotides is shielding the exterior of delivery vehicles with polyethylene glycol (PEG). This strategy may prevent the non-specific function of particles with immune cells and other non-target tissues. Although a variety of delivery systems has been developed in the laboratory, challenges remain in bringing the full potential of RNAi to clinical approaches [156]. circRNAs however, offer significant increases in stability over current strategies.

Conclusions and perspectives

Following advancements in high-throughput sequencing, the field of circRNAs has attracted more attention and is currently an area of intense interest in the field of cancer research. circRNAs are an ideal biomarker in cancer, and are stably expressed in exosomes, blood, and saliva, where specific circRNAs have been indicated as promising prognostic or diagnostic biomarkers already.

Abnormal expression of circRNAs has been observed in a wide range of human malignancies and their dysregulation can alter gene expression networks, leading to dramatic changes in cell fates, including cancer initiation and progression. circRNAs can be both oncogenic and anti-oncogenic, so could potentially be utilized in the treatment and prognosis of colorectal cancer. Although recent advances on circRNAs have highlighted some interesting insights, much work remains to be done to translate circRNAs into clinical application for clinical patient benefit. Major hurdles include the development of an efficient siRNAs delivery system, and the assessment of safety and side effects, yet, clearly circRNAs have significant potential for the treatment and diagnosis of CRC.

Availability of data and materials

Data will be provided based on reasonable request.

Abbreviations

ceRNA:

Competing endogenous RNA

circRNAs:

Circular RNAs

siRNA:

Small interacting RNA

ncRNA:

Noncoding RNA

HNPCC:

Hereditary nonpolyposis colorectal cancer

ciRNAs:

Intronic circRNAs

ecircRNA:

Exonic circRNAs

ELciRNA:

Exon–intron-circRNAs

miRNA:

MicroRNA

RBP:

RNA-binding protein

PEG:

Polyethylene glycol

CRC:

Colorectal cancer

References

  1. Keum NN, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–32.

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–64.

    Article  PubMed  Google Scholar 

  3. Zheng Y, Hua X, Win AK, MacInnis RJ, Gallinger S, Le Marchand L, et al. A new comprehensive colorectal cancer risk prediction model incorporating family history, personal characteristics, and environmental factors. Cancer Epidemiol Biomarkers Prev. 2020;29(3):549–57.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, et al. Colorectal cancer. Nat Rev Dis Prim [Internet]. 2015;1:15065.

    Article  Google Scholar 

  5. Koveitypour Z, Panahi F, Vakilian M, Peymani M, Seyed Forootan F, Nasr Esfahani MH, et al. Signaling pathways involved in colorectal cancer progression. In: Cell and bioscience, vol. 9. BioMed Central Ltd.; 2019. https://pubmed.ncbi.nlm.nih.gov/31827763/

  6. Gausachs M, Borras E, Chang K, Gonzalez S, Azuara D, Amador AD, et al. Mutational heterogeneity in APC and KRAS arises at the crypt level and leads to polyclonality in early colorectal tumorigenesis. Clin Cancer Res. 2017;23(19):5936–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance—PubMed. https://pubmed.ncbi.nlm.nih.gov/15943410/

  8. Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology. 2010;138(6):2059–72.

    Article  CAS  PubMed  Google Scholar 

  9. Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017;18(1):197. https://doi.org/10.3390/ijms18010197.

    Article  CAS  PubMed Central  Google Scholar 

  10. Collura A, Lefevre JH, Svrcek M, Tougeron D, Zaanan A, Duval A. Microsatellite instability and cancer: from genomic instability to personalized medicine. Medecine/sciences, vol. 35. Editions EDK; 2019. p. 535–43. https://pubmed.ncbi.nlm.nih.gov/31274083/

  11. Wang X, Wang D, Zhang H, Feng M, Wu X. Genome-wide analysis of DNA methylation identifies two CpG sites for the early screening of colorectal cancer. Epigenomics. 2020;12(1):37–52.

    Article  CAS  PubMed  Google Scholar 

  12. Okita A, Takahashi S, Ouchi K, Inoue M, Watanabe M, Endo M, et al. Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer. Oncotarget. 2018;9(27):18698–711.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Slaby O, Laga R, Sedlacek O. Therapeutic targeting of non-coding RNAs in cancer. Biochemical journal, vol. 474. Portland Press Ltd; 2017. p. 4219–51. https://pubmed.ncbi.nlm.nih.gov/29242381/

  14. Matsui M, Corey DR. Non-coding RNAs as drug targets. Nature reviews drug discovery, vol. 16. Nature Publishing Group; 2017. p. 167–79. https://pubmed.ncbi.nlm.nih.gov/27444227/

  15. Panni S, Lovering RC, Porras P, Orchard S. Non-coding RNA regulatory networks. Biochimica et Biophysica Acta—gene regulatory mechanisms, vol. 1863. Elsevier B.V.; 2020. https://pubmed.ncbi.nlm.nih.gov/31493559/

  16. Hao S, Cong L, Qu R, Liu R, Zhang G, Li Y. Emerging roles of circular RNAs in colorectal cancer. OncoTargets and therapy, vol. 12. Dove Medical Press Ltd.; 2019. p. 4765–77. https://pubmed.ncbi.nlm.nih.gov/31354303/

  17. Akhade VS, Pal D, Kanduri C. Long noncoding RNA: genome organization and mechanism of action. Adv Exp Med Biol. 2017;1008:47–74.

    Article  CAS  PubMed  Google Scholar 

  18. Ameli-Mojarad M, Ameli-Mojarad M, Nourbakhsh M, Nazemalhosseini-Mojarad E. Circular RNA hsa_circ_0005046 and hsa_circ_0001791 may become diagnostic biomarkers for breast cancer early detection. J Oncol. 2021;2021:1–7.

    Article  Google Scholar 

  19. Tian D, Xiang Y, Tang Y, Ge Z, Li Q, Zhang Y. Circ-ADAM9 targeting PTEN and ATG7 promotes autophagy and apoptosis of diabetic endothelial progenitor cells by sponging mir-20a-5p. Cell Death Dis. 2020;11(7):526.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Jakobi T, Czaja-Hasse LF, Reinhardt R, Dieterich C. Profiling and validation of the circular RNA repertoire in adult murine hearts. Genomics, proteomics and bioinformatics, vol. 14. Beijing Genomics Institute; 2016. p. 216–23.

  21. St Laurent G, Wahlestedt C, Kapranov P. The landscape of long noncoding RNA classification. Trends Genet. 2015;31(5):239–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R, et al. Circular RNAs: Biogenesis, function and role in human diseases. Frontiers in molecular biosciences, vol. 4. Frontiers Media S.A.; 2017. https://pubmed.ncbi.nlm.nih.gov/28634583/

  23. Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–8.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wang M, Yu F, Li P. Circular RNAs: Characteristics, function and clinical significance in hepatocellular carcinoma. In: Cancers, vol. 10. MDPI AG; 2018. https://pubmed.ncbi.nlm.nih.gov/30072625/

  25. Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, et al. CircRNA biogenesis competes with Pre-mRNA splicing. Mol Cell. 2014;56(1):55–66.

    Article  CAS  PubMed  Google Scholar 

  26. Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–34.

    Article  CAS  PubMed  Google Scholar 

  27. Pan H, Li T, Jiang Y, Pan C, Ding Y, Huang Z, et al. Overexpression of circular RNA ciRS-7 abrogates the tumor suppressive effect of miR-7 on gastric cancer via PTEN/PI3K/AKT signaling pathway. J Cell Biochem. 2018;119(1):440–6.

    Article  CAS  PubMed  Google Scholar 

  28. Liu L, Liu FB, Huang M, Xie K, Xie QS, Liu CH, et al. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway. Hepatobiliary Pancreat Dis Int. 2019;18(6):580–6.

    Article  PubMed  Google Scholar 

  29. Capel B, Swain A, Nicolis S, Hacker A, Walter M, Koopman P, et al. Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell. 1993;73(5):1019–30.

    Article  CAS  PubMed  Google Scholar 

  30. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–8.

    Article  CAS  PubMed  Google Scholar 

  31. Huang G, Zhu H, Shi Y, Wu W, Cai H, Chen X. Cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/β-Catenin Pathway. PLoS ONE. 2015;10(6):e0131225.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Chen CY, Sarnow P. Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science. 1995;268(5209):415–7.

    Article  CAS  PubMed  Google Scholar 

  33. Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, et al. Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis. Mol Cell. 2017;66(1):22-37.e9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao F, et al. Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis. J Natl Cancer Inst. 2018;110(3):304–15.

    Article  CAS  Google Scholar 

  35. Abe N, Matsumoto K, Nishihara M, Nakano Y, Shibata A, Maruyama H, et al. Rolling circle translation of circular RNA in living human cells. Sci Rep. 2015;5(1):1–9.

    Article  CAS  Google Scholar 

  36. Yu CY, Kuo HC. The emerging roles and functions of circular RNAs and their generation. Journal of biomedical science, vol. 26. BioMed Central Ltd.; 2019. p. 1–12. Doi: https://doi.org/10.1186/s12929-019-0523-z

  37. Xiao H, Liu M. Circular RNA hsa_circ_0053277 promotes the development of colorectal cancer by upregulating matrix metallopeptidase 14 via miR-2467–3p sequestration. J Cell Physiol. 2020;235(3):2881–90.

    Article  CAS  PubMed  Google Scholar 

  38. Li XN, Wang ZJ, Ye CX, Zhao BC, Huang XX, Yang L. Circular RNA circVAPA is up-regulated and exerts oncogenic properties by sponging miR-101 in colorectal cancer. Biomed Pharmacother. 2019;112:108611.

    Article  CAS  PubMed  Google Scholar 

  39. Liang Y, Shi J, He Q, Sun G, Gao L, Ye J, et al. Hsa_circ_0026416 promotes proliferation and migration in colorectal cancer via miR-346/NFIB axis. Cancer Cell Int. 2020;20(1):1–15.

    Article  CAS  Google Scholar 

  40. Zhang X, Xu Y, Yamaguchi K, Hu J, Zhang L, Wang J, et al. Circular RNA circVAPA knockdown suppresses colorectal cancer cell growth process by regulating miR-125a/CREB5 axis. Cancer Cell Int. 2020;20(1):1–11.

    Article  CAS  Google Scholar 

  41. Jin C, Wang A, Liu L, Wang G, Li G. Hsa_circ_0136666 promotes the proliferation and invasion of colorectal cancer through miR-136/SH2B1 axis. J Cell Physiol. 2019;234(5):7247–56.

    Article  CAS  PubMed  Google Scholar 

  42. Wang X, Zhang Y, Huang L, et al. Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances. Int J Clin Exp Pathol. 2015;8(12):16020–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Geng Y, Zheng X, Hu W, Wang Q, Xu Y, He W, et al. Hsa circ 0009361 acts as the sponge of miR-582 to suppress colorectal cancer progression by regulating APC2 expression. Clin Sci. 2019;133(10):1197–213.

    Article  CAS  Google Scholar 

  44. Li X, Wang J, Zhang C, Lin C, Zhang J, Zhang W, et al. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. J Pathol. 2018;246(2):166–79.

    Article  CAS  PubMed  Google Scholar 

  45. Yang G, Zhang T, Ye J, Yang J, Chen C, Cai S, et al. Circ-ITGA7 sponges miR-3187-3p to upregulate ASXL1, suppressing colorectal cancer proliferation. Cancer Manag Res. 2019;11:6499–509.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Lu H, Yao B, Wen X, Jia B. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo. BMC Cancer. 2019;19(1):918.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  47. Lu C, Jiang W, Hui B, Rong D, Fu K, Dong C, et al. The circ_0021977/miR-10b-5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancer. J Cell Physiol. 2020;235(3):2273–85.

    Article  CAS  PubMed  Google Scholar 

  48. Wen T, Wu H, Zhang L, Li K, Xiao X, Zhang L, et al. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455–5p/SGK1 axis in colorectal cancer. Anticancer Drugs. 2020;32(1):22–33.

    Article  CAS  Google Scholar 

  49. He JH, Li YG, Han ZP, Zhou JB, Chen WM, Lv YB, et al. The CircRNA-ACAP2/Hsa-miR-21–5p/Tiam1 regulatory feedback circuit affects the proliferation, migration, and invasion of colon cancer SW480 cells. Cell Physiol Biochem. 2018;49(4):1539–50.

    Article  CAS  PubMed  Google Scholar 

  50. Han K, Wang FW, Cao CH, Ling H, Chen JW, Chen RX, et al. CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17. Mol Cancer. 2020;19(1):1–18.

    Article  Google Scholar 

  51. Yang H, Li X, Meng Q, Sun H, Wu S, Hu W, et al. CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer. Mol Cancer. 2020;19(1):1–15.

    Article  Google Scholar 

  52. Shang A, Gu C, Wang W, Wang X, Sun J, Zeng B, et al. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p-TGF-β1 axis. Mol Cancer. 2020;19(1):1–15.

    Article  CAS  Google Scholar 

  53. Jian X, He H, Zhu J, Zhang Q, Zheng Z, Liang X, et al. Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340. Mol Cancer. 2020;19(1):20. https://doi.org/10.1186/s12943-020-1134-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Chen MS, Lin CH, Huang LY, Qiu XM. Circrna smarcc1 sponges mir-140–3p to regulate cell progression in colorectal cancer. Cancer Manag Res. 2020;12:4899–910.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Yan Y, Su M, Qin B. CircHIPK3 promotes colorectal cancer cells proliferation and metastasis via modulating of miR-1207-5p/FMNL2 signal. Biochem Biophys Res Commun. 2020;524(4):839–46.

    Article  CAS  PubMed  Google Scholar 

  56. Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T, et al. CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7 article. Cell Death Dis. 2018;9(4):1–15.

    Article  CAS  Google Scholar 

  57. Chen HY, Li XN, Ye CX, Chen ZL, Wang ZJ. Circular RNA circHUWE1 is upregulated and promotes cell proliferation, migration and invasion in colorectal cancer by sponging mir-486. Onco Targets Ther. 2020;13:423–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Wu HB, Huang SS, Lu CG, Tian SD, Chen M. CircAPLP2 regulates the proliferation and metastasis of colorectal cancer by targeting miR-101-3p to activate the Notch signalling pathway. Am J Transl Res. 2020;12(6):2554–69.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Lu C, Fu L, Qian X, Dou L, Cang S. Knockdown of circular RNA circ-FARSA restricts colorectal cancer cell growth through regulation of miR-330–5p/LASP1 axis. Arch Biochem Biophys. 2020;689:108434.

    Article  CAS  PubMed  Google Scholar 

  60. Zhang L, Dong X, Yan B, Yu W, Shan L. CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1. Cell Death Dis. 2020;11(7):1–15. https://doi.org/10.1038/s41419-020-2707-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Ma Z, Han C, Xia W, Wang S, Li X, Fang P, et al. circ5615 functions as a ceRNA to promote colorectal cancer progression by upregulating TNKS. Cell Death Dis. 2020;11(5):1–14. https://doi.org/10.1038/s41419-020-2514-0.

    Article  CAS  Google Scholar 

  62. Chen C, Huang Z, Mo X, Song Y, Li X, Li X, et al. The circular RNA 001971/miR-29c-3p axis modulates colorectal cancer growth, metastasis, and angiogenesis through VEGFA. J Exp Clin Cancer Res. 2020;39(1):1–15.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Yang B, Du K, Yang C, Xiang L, Xu Y, Cao C, et al. CircPRMT5 circular RNA promotes proliferation of colorectal cancer through sponging miR-377 to induce E2F3 expression. J Cell Mol Med. 2020;24(6):3431–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Wang X, Tao G, Huang D, Liang S, Zheng D. Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA-485–5p/CKS1B axis. Oncol Rep. 2020;44(5):2009–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Du J, Xu J, Chen J, Liu W, Wang P, Ye K. CircRAE1 promotes colorectal cancer cell migration and invasion by modulating miR-338–3p/TYRO3 axis. Cancer Cell Int. 2020;20(1):1–14.

    Article  CAS  Google Scholar 

  66. Lai M, Liu G, Li R, Bai H, Zhao J, Xiao P, et al. Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-α pathway in human colon cancer. J Cell Mol Med. 2020;24(9):5021–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Li Y, Zang H, Zhang X, Huang G. Circ_0136666 facilitates the progression of colorectal cancer via mir-383/creb1 axis. Cancer Manag Res. 2020;12:6795–806.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Li C, Zhou H. Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR-761-mediated Ras and Rab interactor 1 signaling. Cancer Med. 2020;9(18):6710–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Wang X, Zhang H, Yang H, Bai M, Ning T, Deng T, et al. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 2020;14(3):539–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Zhang K, Li S, Gu D, Xu K, Zheng R, Xin J, et al. Genetic variants in circTUBB interacting with smoking can enhance colorectal cancer risk. Arch Toxicol. 2020;94(1):325–33.

    Article  CAS  PubMed  Google Scholar 

  71. Li Y, Pei F, Cao M. CircRNA_101951 promotes migration and invasion of colorectal cancer cells by regulating the KIF3A-mediated EMT pathway. Exp Ther Med. 2020;19(5):3355–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Xie Y, Li J, Li P, Li N, Zhang Y, Binang H, et al. RNA-Seq profiling of serum exosomal circular RNAs reveals Circ-PNN as a potential biomarker for human colorectal cancer. Front Oncol. 2020;10:982.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Zhao H, Chen S, Fu Q. Exosomes from CD133+ cells carrying circ-ABCC1 mediate cell stemness and metastasis in colorectal cancer. J Cell Biochem. 2020;121(5–6):3286–97. https://doi.org/10.1002/jcb.29600.

    Article  CAS  PubMed  Google Scholar 

  74. Zeng W, Liu Y, Li WT, Li Y, Zhu JF. CircFNDC3B sequestrates miR-937–5p to derepress TIMP3 and inhibit colorectal cancer progression. Mol Oncol. 2020;14(11):2960–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Wang X, Ren Y, Ma S, Wang S. Circular rna 0060745, a novel circrna, promotes colorectal cancer cell proliferation and metastasis through mir-4736 sponging. Onco Targets Ther. 2020;13:1941–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Chen ZL, Li XN, Ye CX, Chen HY, Wang ZJ. Elevated levels of circrunx1 in colorectal cancer promote cell growth and metastasis via MiR-145-5p/IGF1 signalling. Onco Targets Ther. 2020;13:4035–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Du J, Zhang L, Ma H, Wang Y, Wang P. Retraction: Lidocaine suppresses cell proliferation and aerobic glycolysis by regulating circHOMER1/miR-138–5p/HEY1 axis in colorectal cancer [retraction] (Cancer Manag Res. 2020;12:5009–5022). In: Cancer management and research, vol. 12. Dove Medical Press Ltd; 2020. p. 7341.

  78. Sun J, Liu J, Zhu Q, Xu F, Kang L, Shi X. Hsa_circ_0001806 acts as a ceRNA to facilitate the stemness of colorectal cancer cells by increasing COL1A1. Onco Targets Ther. 2020;13:6315–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Zhao JP, Chen LL. Circular RNA MAT2B induces colorectal cancer proliferation via sponging miR-610, resulting in an increased E2F1 expression. Cancer Manag Res. 2020;12:7107–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Wang L, Wu H, Chu F, Zhang L, Xiao X. Knockdown of circ_0000512 inhibits cell proliferation and promotes apoptosis in colorectal cancer by regulating miR-296–5p/RUNX1 axis. Onco Targets Ther. 2020;13:7357–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Zheng X, Ma YF, Zhang XR, Li Y, Zhao HH, Han SG. Circ-0056618 promoted cell proliferation, migration and angiogenesis through sponging with miR-206 and upregulating CXCR4 and VEGF-A in colorectal cancer. Eur Rev Med Pharmacol Sci. 2020;24(8):4190–202.

    CAS  PubMed  Google Scholar 

  82. Deng Z, Li X, Wang H, Geng Y, Cai Y, Tang Y, et al. Dysregulation of CircRNA_0001946 contributes to the proliferation and metastasis of colorectal cancer cells by targeting MicroRNA-135a-5p. Front Genet. 2020;11:357.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Du H, He Z, Feng F, Chen D, Zhang L, Bai J, et al. Hsa_circ_0038646 promotes cell proliferation and migration in colorectal cancer via miR-331-3p/GRIK3. Oncol Lett. 2020;20(1):266–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  84. Wang Y, Wang H, Zhang J, Chu Z, Liu P, Zhang X, et al. Circ_0007031 serves as a sponge of MiR-760 to regulate the growth and chemoradiotherapy resistance of colorectal cancer via regulating dcp1a. Cancer Manag Res. 2020;12:8465–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Chen H, Pei L, Xie P, Guo G. Circ-prkdc contributes to 5-fluorouracil resistance of colorectal cancer cells by regulating mir-375/foxm1 axis and wnt/β-catenin pathway. Onco Targets Ther. 2020;13:5939–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Dai J, Zhuang Y, Tang M, Qian Q, Chen JP. CircRNA UBAP2 facilitates the progression of colorectal cancer by regulating miR-199a/VEGFA pathway. Eur Rev Med Pharmacol Sci. 2020;24(15):7963–71.

    CAS  PubMed  Google Scholar 

  87. Liu Y, Li H, Ye X, Ji A, Fu X, Wu H, et al. Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502–5p/MYO6 axis. World J Surg Oncol. 2020;18(1):1–13.

    Article  Google Scholar 

  88. Chen J, Yang X, Liu R, Wen C, Wang H, Huang L, et al. Circular RNA GLIS2 promotes colorectal cancer cell motility via activation of the NF-κB pathway. Cell Death Dis. 2020;11(9):1–13.

    Article  Google Scholar 

  89. Lin YC, Yu YS, Lin HH, Hsiao KY. Oxaliplatin-induced DHX9 phosphorylation promotes oncogenic circular RNA CCDC66 expression and development of chemoresistance. Cancers (Basel). 2020;12(3):697.

    Article  CAS  Google Scholar 

  90. Feng J, Li Z, Li L, Xie H, Lu Q, He X. Hypoxia-induced circCCDC66 promotes the tumorigenesis of colorectal cancer via the miR-3140/autophagy pathway. Int J Mol Med. 2020;46(6):1973–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Hsiao KY, Lin YC, Gupta SK, Chang N, Yen L, Sun HS, et al. Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res. 2017;77(9):2339–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Wang X, Chen Y, Liu W, Liu T, Sun D. Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa-miR-1184 and releasing AJUBA and inactivating Hippo/YAP signalling. J Cell Mol Med. 2020;24(17):9908–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. DING DY, WANG D, SHU ZB. Erratum: Hsa_circ_0007534 knockdown represses the development of colorectal cancer cells through regulating miR-613/SLC25A22 axis (European Review for Medical and Pharmacological Sciences (2020) 24:6 (3004–3022) DOI: https://doi.org/10.26355/eurrev_202003_20665). European Review for Medical and Pharmacological Sciences, vol. 25. Verduci Editore s.r.l; 2021. p. 570.

  94. Hu B, Xian Z, Zou Q, Zhang D, Su D, Yao J, et al. CircFAT1 suppresses colorectal cancer development through regulating miR-520b/UHRF1 axis or miR-302c-3p/UHRF1 axis. Cancer Biother Radiopharm. 2021;36(1):45–57. https://doi.org/10.1089/cbr.2019.3291.

    Article  CAS  PubMed  Google Scholar 

  95. Xiao YS, Tong HZ, Yuan XH, Xiong CH, Xu XY, Zeng YF. CircFADS2: a potential prognostic biomarker of colorectal cancer. Exp Biol Med. 2020;245(14):1233–41. https://doi.org/10.1177/1535370220929965.

    Article  CAS  Google Scholar 

  96. Hao Q, Zhang Z. Hsa_circRNA_000166 facilitated cell growth and limited apoptosis through targeting miR-326/LASP1 axis in colorectal cancer. Gastroenterol Res Pract. 2020;2020:8834359. https://doi.org/10.1155/2020/8834359.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Chen LY, Zhi Z, Wang L, Zhao YY, Deng M, Liu YH, et al. NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p-mediated DDR1 and JAG1 signalling. J Pathol. 2019;248(1):103–15.

    Article  CAS  PubMed  Google Scholar 

  98. Zhang ZJ, Zhang YH, Qin XJ, Wang YX, Fu J. Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis. Eur Rev Med Pharmacol Sci. 2020;24(5):2387–400.

    PubMed  Google Scholar 

  99. Zhi X, Zhang J, Cheng Z, Bian L, Qin J. circLgr4 drives colorectal tumorigenesis and invasion through Lgr4-targeting peptide. Int J Cancer. 2019. https://doi.org/10.1002/ijc.32549.

    Article  PubMed  Google Scholar 

  100. Xu XW, Zheng BA, Hu ZM, Qian ZY, Huang CJ, Liu XQ, et al. Circular RNA hsa_circ_000984 promotes colon cancer growth and metastasis by sponging miR-106b. Oncotarget. 2017;8(53):91674–83.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Li W, Xu Y, Wang X, Cao G, Bu W, Wang X, et al. CircCCT3 modulates vascular endothelial growth factor A and Wnt signaling to enhance colorectal cancer metastasis through sponging miR-613. DNA Cell Biol. 2020;39(1):118–25.

    Article  CAS  PubMed  Google Scholar 

  102. Zhou C, Liu HS, Wang FW, Hu T, Liang ZX, Lan N, et al. circCAMSAP1 promotes tumor growth in colorectal cancer via the miR-328-5p/E2F1 axis. Mol Ther. 2020;28(3):914–28.

    Article  CAS  PubMed  Google Scholar 

  103. He JH, Han ZP, Luo JG, Jiang JW, Zhou JB, Chen WM, et al. Hsa_Circ_0007843 acts as a mIR-518c-5p sponge to regulate the migration and invasion of colon cancer SW480 cells. Front Genet. 2020;11:1. https://doi.org/10.3389/fgene.2020.00009/full.

    Article  Google Scholar 

  104. Zhang J, Wang H, Wu K, Zhan F, Zeng H. Dysregulated circRNA_100876 contributes to proliferation and metastasis of colorectal cancer by targeting microRNA-516b (miR-516b). Cancer Biol Ther. 2020;21(8):733–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Xu H, Liu Y, Cheng P, Wang C, Liu Y, Zhou W, et al. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis. J Exp Clin Cancer Res. 2020;39(1):1–17.

    Article  CAS  Google Scholar 

  106. Wu M, Kong C, Cai M, Huang W, Chen Y, Wang B, et al. Hsa_circRNA_002144 promotes growth and metastasis of colorectal cancer through regulating miR-615–5p/LARP1/mTOR pathway. Carcinogenesis. 2020;42(4):601–10.

    Article  PubMed Central  Google Scholar 

  107. Chen LY, Wang L, Ren YX, Pang Z, Liu Y, Sun XD, et al. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138–5p/4EBP-1 mediated cap-independent HIF-1α translation. Mol Cancer. 2020;19(1):1–17.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Liu K, Mou Y, Shi X, Liu T, Chen Z, Zuo X. Circular RNA 100146 promotes colorectal cancer progression by the MicroRNA 149/HMGA2 Axis. Mol Cell Biol. 2020;41(2):e00445-20.

    Article  Google Scholar 

  109. Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ, Ma XD, et al. N 6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 2019;10(1):1–15.

    Article  CAS  Google Scholar 

  110. Pei FL, Cao MZ, Li YF. Circ_0000218 plays a carcinogenic role in colorectal cancer progression by regulating miR-139–3p/RAB1A axis. J Infect Dis. 2019;220(4):55–65.

    Google Scholar 

  111. Li Y, Li C, Xu R, Wang Y, Li D, Zhang B. A novel circFMN2 promotes tumor proliferation in CRC by regulating the miR-1182/hTERT signaling pathways. Clin Sci. 2019;133(24):2463–79.

    Article  CAS  Google Scholar 

  112. Abu N, Hon KW, Jeyaraman S, Yahaya A, Abdullah NMA, Mustangin M, et al. Identification of differentially expressed circular RNAs in chemoresistant colorectal cancer. Epigenomics. 2019;11(8):875–84.

    Article  CAS  PubMed  Google Scholar 

  113. Li Q, Wang Y, Wu S, Zhou Z, Ding X, Shi R, et al. CircACC1 regulates assembly and activation of AMPK complex under metabolic stress. Cell Metab. 2019;30(1):157-173.e7.

    Article  PubMed  CAS  Google Scholar 

  114. Li R, Wu B, Xia J, Ye L, Yang X. Circular RNA hsa_circRNA_102958 promotes tumorigenesis of colorectal cancer via miR-585/CDC25B axis. Cancer Manag Res. 2019;11:6887–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Chen Z, Ren R, Wan D, Wang Y, Xue X, Jiang M, et al. Hsa_circ_101555 functions as a competing endogenous RNA of miR-597–5p to promote colorectal cancer progression. Oncogene. 2019;38(32):6017–34.

    Article  CAS  PubMed  Google Scholar 

  116. Lu X, Yu Y, Liao F, Tan S. Homo sapiens circular RNA 0079993 (hsa-circ-0079993) of the POLR2J4 gene acts as an oncogene in colorectal cancer through the microRNA-203a-3p.1 and CREB1 axis. Med Sci Monit. 2019;25:6872–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Zhang Q, Zhang C, Ma JX, Ren H, Sun Y, Xu JZ. Circular rna pip5k1a promotes colon cancer development through inhibiting mir-1273a. World J Gastroenterol. 2019;25(35):5300–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Zhang J, Liu H, Zhao P, Zhou H, Mao T. Has_circ_0055625 from circRNA profile increases colon cancer cell growth by sponging miR-106b-5p. J Cell Biochem. 2019;120(3):3027–37.

    Article  CAS  PubMed  Google Scholar 

  119. Yong W, Zhuoqi X, Baocheng W, Dongsheng Z, Chuan Z, Yueming S. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer. Biomed Pharmacother. 2018;102:1188–94.

    Article  PubMed  CAS  Google Scholar 

  120. Chen L, Zhang S, Wu J, Cui J, Zhong L, Zeng L, et al. CircRNA-100290 plays a role in oral cancer by functioning as a sponge of the MIR-29 family. In: Oncogene, vol. 36. Nature Publishing Group; 2017. p. 4551–61.

  121. Weng W, Wei Q, Toden S, Yoshida K, Nagasaka T, Fujiwara T, et al. Circular RNA ciRS-7—a promising prognostic biomarker and a potential therapeutic target in colorectal cancer. Clin Cancer Res. 2017;23(14):3918–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Xiong W, Ai YQ, Li YF, Ye Q, Chen ZT, Qin JY, Liu QY, Wang H, Ju YH, Li WH, Li YF. Microarray analysis of circular RNA expression profile associated with 5-fluorouracil-based chemoradiation resistance in colorectal cancer cells. Biomed Res Int. 2017;2017:8421614. https://doi.org/10.1155/2017/8421614.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Han J, Zhao G, Ma X, Dong Q, Zhang H, Wang Y, et al. CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression. Biochem Biophys Res Commun. 2018;503(4):2429–35.

    Article  CAS  PubMed  Google Scholar 

  124. Wang L, Peng X, Lu X, Wei Q, Chen M, Liu L. Inhibition of hsa_circ_0001313 (circCCDC66) induction enhances the radio-sensitivity of colon cancer cells via tumor suppressor miR-338–3p: Effects of cicr_0001313 on colon cancer radio-sensitivity. Pathol Res Pract. 2019;215(4):689–96.

    Article  CAS  PubMed  Google Scholar 

  125. Xie H, Ren X, Xin S, Lan X, Lu G, Lin Y, et al. Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer. Oncotarget. 2016;7(18):26680–91.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Huang X, Shen X, Peng L, Mai W, Wang Y, Zheng H. CircCSNK1G1 contributes to the development of colorectal cancer by increasing the expression of MYO6 via competitively targeting miR-455–3p. Cancer Manag Res. 2020;12:9563–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Li Z, Yao H, Wang S, Li G, Gu X. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis. J Exp Clin Cancer Res. 2020;39(1):1–14.

    PubMed  PubMed Central  CAS  Google Scholar 

  128. Wang DK, Chong RF, Song BL, Fan KF, Liu YF. Circular RNA circ-SMAD7 is downregulated in colorectal cancer and suppresses tumor metastasis by regulating epithelial mesenchymal transition. Eur Rev Med Pharmacol Sci. 2020;24(4):1736–42.

    PubMed  Google Scholar 

  129. Xu B, Yang N, Liu Y, Kong P, Han M, Li B. Circ_cse1l inhibits colorectal cancer proliferation by binding to eIF4A3. Med Sci Monit. 2020;26:e923876-1.

    Article  Google Scholar 

  130. Huang G, Ma J, Zhang L. Integrin subunit alpha 5 (ITGA5) gene circular rna sponges microrna-107 in colorectal carcinoma cells and tissues and regulates the expression of the forkhead box J3 (FOXJ3) gene. Med Sci Monit. 2020;26:e920623-1.

    Article  Google Scholar 

  131. Ren TJ, Liu C, Hou JF, Shan FX. CircDDX17 reduces 5-fluorouracil resistance and hinders tumorigenesis in colorectal cancer by regulating miR-31–5p/KANK1 axis. Eur Rev Med Pharmacol Sci. 2020;24(4):1743–54.

    PubMed  Google Scholar 

  132. Yang Z, Zhang J, Lu D, Sun Y, Zhao X, Wang X, et al. Hsa_circ_0137008 suppresses the malignant phenotype in colorectal cancer by acting as a microRNA-338–5p sponge. Cancer Cell Int. 2020;20(1):1–12.

    CAS  Google Scholar 

  133. Zhang Y, Zhang Z, Yi Y, Wang Y, Fu J. CircNOL10 acts as a sponge of miR-135a/b-5p in suppressing colorectal cancer progression via regulating KLF9. Onco Targets Ther. 2020;13:5165–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Li H, Jin X, Liu B, Zhang P, Chen W, Li Q. CircRNA CBL.11 suppresses cell proliferation by sponging miR-6778–5p in colorectal cancer. BMC Cancer. 2019;19(1):1–14.

    Google Scholar 

  135. Cui W, Dai J, Ma J, Gu H. Circcdyl/microRNA-150–5p participates in modulating growth and migration of colon cancer cells. Gen Physiol Biophys. 2019;38(6):485–95.

    Article  CAS  PubMed  Google Scholar 

  136. Jin Y, Yu LL, Zhang B, Liu CF, Chen Y. Circular RNA hsa_circ_0000523 regulates the proliferation and apoptosis of colorectal cancer cells as miRNA sponge. Braz J Med Biol Res. 2018;51(12).

  137. Raza U, Zhang JD, Şahin Ö. MicroRNAs: Master regulators of drug resistance, stemness, and metastasis. In: Journal of molecular medicine, vol. 92. Springer Verlag; 2014. p. 321–36.

  138. Wr J, Ne S. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–61.

    Article  CAS  Google Scholar 

  139. Jin Y, Yu LL, Zhang B, Liu CF, Chen Y. Circular RNA hsa_circ_0000523 regulates the proliferation and apoptosis of colorectal cancer cells as miRNA sponge. Braz J Med Biol Res. 2018;51(12):e7811. https://doi.org/10.1590/1414-431X20187811.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Yang N, Xu B, Kong P, Han M, Li BH. Hsa_circ_0002320: a novel clinical biomarker for colorectal cancer prognosis. Medicine (Baltimore). 2020;99(28):e21224.

    Article  CAS  Google Scholar 

  141. Tang X, Sun G, He Q, Wang C, Shi J, Gao L, et al. Circular noncoding RNA circMBOAT2 is a novel tumor marker and regulates proliferation/migration by sponging miR-519d-3p in colorectal cancer. Cell Death Dis. 2020;11(8):1–15.

    Article  CAS  Google Scholar 

  142. Sadeghi H, Heiat M. A novel circular RNA hsa_circ_0060927 may serve as a potential diagnostic biomarker for human colorectal cancer. Mol Biol Rep. 2020;47(9):6649–55.

    Article  CAS  PubMed  Google Scholar 

  143. Jin YD, Ren YR, Gao YX, Zhang L, Ding Z. Hsa_circ_0005075 predicts a poor prognosis and acts as an oncogene in colorectal cancer via activating Wnt/β-catenin pathway. Eur Rev Med Pharmacol Sci. 2019;23(8):3311–9.

    PubMed  Google Scholar 

  144. Xing L, Xia M, Jiao X, Fan L. Hsa_circ_0004831 serves as a blood-based prognostic biomarker for colorectal cancer and its potentially circRNA-miRNA-mRNA regulatory network construction. Cancer Cell Int. 2020;20(1):1–9.

    Article  CAS  Google Scholar 

  145. Min L, Wang H, Zeng Y. CircRNA-104916 regulates migration, apoptosis and epithelial-mesenchymal transition in colon cancer cells. Front Biosci Landmark. 2019;24:819–32. https://doi.org/10.2741/4753.

    Article  Google Scholar 

  146. Tian J, Xi X, Wang J, Yu J, Huang Q, Ma R, et al. CircRNA hsa_circ_0004585 as a potential biomarker for colorectal cancer. Cancer Manag Res. 2019;11:5413–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Pan B, Qin J, Liu X, He B, Wang X, Pan Y, et al. Identification of serum exosomal hsa-circ-0004771 as a novel diagnostic biomarker of colorectal cancer. Front Genet. 2019;10:1096.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  148. Zheng X, Chen L, Zhou Y, Wang Q, Zheng Z, Xu B, et al. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Mol Cancer. 2019;18(1):1–13.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Gi Z, Li LF, Wang CY, Wang Y, Ma WL. CircMTO1 inhibits cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway in colorectal cancer. Eur Rev Med Pharmacol Sci. 2018;22(23):8203–9.

    Google Scholar 

  150. Ji W, Qiu C, Wang M, Mao N, Wu S, Dai Y. Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer. Biochem Biophys Res Commun. 2018;497(1):122–6.

    Article  CAS  PubMed  Google Scholar 

  151. Wang F, Wang J, Cao X, Xu L, Chen L. Hsa_circ_0014717 is downregulated in colorectal cancer and inhibits tumor growth by promoting p16 expression. Biomed Pharmacother. 2018;98:775–82.

    Article  CAS  PubMed  Google Scholar 

  152. Li J, Ni S, Zhou C, Ye M. The expression profile and clinical application potential of hsa_circ_0000711 in colorectal cancer. Cancer Manag Res. 2018;10:2777–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  153. Wang J, Li X, Lu L, He L, Hu H, Xu Z. Circular RNA hsa_circ_0000567 can be used as a promising diagnostic biomarker for human colorectal cancer. J Clin Lab Anal. 2018;32(5):e22379.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  154. Zhou F, Lin H, Chen Z, Huang Z, Hu J. The expression profile and clinical significance of circRNA0003906 in colorectal cancer. Onco Targets Ther. 2017;10:5187–93.

    Article  Google Scholar 

  155. Sang M, Meng L, Liu S, Ding P, Chang S, Ju Y, et al. Circular RNA ciRS-7 maintains metastatic phenotypes as a ceRNA of miR-1299 to target MMPs. Mol Cancer Res. 2018;16(11):1665–75.

    Article  CAS  PubMed  Google Scholar 

  156. Kanasty R, Dorkin JR, Vegas A, Anderson D. Delivery materials for siRNA therapeutics. In: Nature materials, vol. 12. Nature Publishing Group; 2013. p. 967–77.

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Biology, Faculty of Basic Science, Kharrazi University, Tehran, Iran

    Mandana Ameli-Mojarad & Melika Ameli-Mojarad

  2. School of Medicine, University of Sunderland, City Campus, Chester Road, Sunderland, SR1 3SD, UK

    Mahrooyeh Hadizadeh & Maziar Ashrafian Bonab

  3. Institute of Health & Life Sciences, De Montfort University, Leicester, UK

    Chris Young

  4. Department of Cell & Molecular Biology, Faculty of Science, Tehran University of Medical Science, Tehran, Iran

    Hosna Babini

  5. Gastroenterology and Liver Disease Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Ehsan Nazemalhosseini-Mojarad

Authors
  1. Mandana Ameli-Mojarad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Melika Ameli-Mojarad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahrooyeh Hadizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chris Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hosna Babini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ehsan Nazemalhosseini-Mojarad
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maziar Ashrafian Bonab
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MA and MA contributed equally in conception, design and data collection and drafting of the manuscript. C.Y and M.H contributed in editing and drafting the manuscript and E. N and M. B were the supervising and revising the manuscript.

Corresponding authors

Correspondence to Ehsan Nazemalhosseini-Mojarad or Maziar Ashrafian Bonab.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no conflict of interest, All authors approved the final version for submission.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ameli-Mojarad, M., Ameli-Mojarad, M., Hadizadeh, M. et al. The effective function of circular RNA in colorectal cancer. Cancer Cell Int 21, 496 (2021). https://doi.org/10.1186/s12935-021-02196-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12935-021-02196-0

Keywords

Cancer Cell International

ISSN: 1475-2867

Contact us